Senators Hassan, Braun and Representatives Kuster, Harshbarger Introduce Bipartisan Bill to Lower Prescription Drug Costs by Cracking Down on Abuses of Medication Patent Process
September 13, 2023
September 13, 2023
WASHINGTON, Sept. 13 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
Senators Maggie Hassan (D-NH) and Mike Braun (R-IN), as well as Representatives Annie Kuster (NH-02) and Diana Harshbarger (TN-01), introduced bipartisan, bicameral legislation to lower prescription drug costs by closing oversight gaps that drug manufacturers take advantage of.
Because of incomplete coordination between the Food and Drug Administration (FDA) and the U.S. Pate . . .
Senators Maggie Hassan (D-NH) and Mike Braun (R-IN), as well as Representatives Annie Kuster (NH-02) and Diana Harshbarger (TN-01), introduced bipartisan, bicameral legislation to lower prescription drug costs by closing oversight gaps that drug manufacturers take advantage of.
Because of incomplete coordination between the Food and Drug Administration (FDA) and the U.S. Pate . . .